Rtw Investments, LP Immunocore Holdings PLC Transaction History
Rtw Investments, LP
- $7.48 Billion
- Q3 2025
A detailed history of Rtw Investments, LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Rtw Investments, LP holds 4,869,798 shares of IMCR stock, worth $175 Million. This represents 2.36% of its overall portfolio holdings.
Number of Shares
4,869,798
Previous 4,869,798
-0.0%
Holding current value
$175 Million
Previous $153 Million
15.77%
% of portfolio
2.36%
Previous 2.35%
Shares
10 transactions
Others Institutions Holding IMCR
# of Institutions
147Shares Held
46.9MCall Options Held
325KPut Options Held
1.74M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.06MShares$254 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA4.78MShares$172 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.75MShares$135 Million0.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.8MShares$101 Million2.17% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$83.5 Million0.69% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.58B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...